This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about growth in the biotech/life sciences segment.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels, 01:18
Carter Williams, CEO and Managing Partner, iSelect Fund, 05:05
Maximilian Bade, Founding Partner, Nucleus Capital, 07:35
Ron Paliwoda, President, Paliwoda Group, 10:34
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund, 16:36
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures, 20:31
Mark Groper, Chief Executive Officer, Orion Biotechnology, 29:20

I hope you enjoy this episode.

For a full transcript, click here.

---

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org       

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/  
For Startups check out: https://tencapital.group/company-landing/  
For eGuides check out: https://tencapital.group/education/  
For upcoming Events, check out https://tencapital.group/events/    

For Feedback please contact info@tencapital.group 

Music courtesy of Bensound.

Copyright (c) 2024, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.